TVA (ABC), LLC

BLEND THERAPEUTICS

Pharmaceuticals, namely, antineoplastics, anti-inflammatories, anti-infectives, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals, cardiovascular pharmaceuticals, dermatological pharmaceutical products, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the treatment and prevention of diseases and disorders of the auto-immune system, the metabolic system, the musculo-skeletal system and the genitourinary system, pharmaceutical preparations for use in hematology and in tissue and organ transplantation, pharmaceutical preparations for the treatment of eye diseases and conditions, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of immune system related diseases and disorders, pharmaceutical preparations for the treatment of kidney diseases, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating hypertension, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for use in urology, pharmaceutical products for ophthalmological use, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical products for the treatment of bone diseases, pharmaceutical products for treating respiratory diseases, pharmaceutical products for treating respiratory diseases and asthma, pharmaceutical preparations for the treatment of sleep disorders and neurological disorders; nano-particles, namely, those composed of polymers, therapeutics, or excipients used for medical diagnostic purposes and for the treatment of cancer, inflammation, cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, infectious diseases, diabetes, impotence, obesity, arthritis and autoimmune disorders; pharmaceuticals and medicines containing nano-particles, for use for the prevention and/or treatment of cancer, cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, infectious diseases, diabetes, impotence, obesity, arthritis and autoimmune disorders, and for use as drug delivery agents consisting of substances that facilitate delivery of a wide range of pharmaceuticals allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals for the treatment of cancer, cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, infectious diseases, diabetes, impotence, obesity, arthritis and autoimmune disorders; vaccines incorporating nano-particles;THERAPEUTICS;Pharmaceutical research and development;

PENTARIN

Pharmaceutical products for the prevention and treatment of hyperproliferative diseases and disorders;Biochemicals for in vitro and in vivo scientific research, medical research and scientific use; Biochemicals, namely, conjugates for in vitro and in vivo scientific research, medical research and scientific use; Biochemicals, namely, conjugates for use in the manufacture of pharmaceuticals for treating hyperproliferative diseases and disorders;Scientific and technological services, namely, scientific research, analysis, development, design and testing in the field of pharmaceuticals for treating hyperproliferative diseases and disorders;

TARVEDA THERAPEUTICS

The wording TARVEDA has no meaning in a foreign language.;THERAPEUTICS;Pharmaceutical research and development;